{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:21:04Z","timestamp":1790774464413,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277110"],"award-info":[{"award-number":["22277110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473761"],"award-info":[{"award-number":["82473761"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903770"],"award-info":[{"award-number":["81903770"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232301420058"],"award-info":[{"award-number":["232301420058"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421243"],"award-info":[{"award-number":["252300421243"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242301420005"],"award-info":[{"award-number":["242301420005"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.drudis.2025.104397","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:06:30Z","timestamp":1749405990000},"page":"104397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epigenetic roles of lysine-specific demethylase 1 (LSD1) in cancer metabolism"],"prefix":"10.1016","volume":"30","author":[{"given":"Bing","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-643X","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104397_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.drudis.2025.104397_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105335","article-title":"Targeting LSD1 for acute myeloid leukemia (AML) treatment","volume":"164","author":"Zhang","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104397_b0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","article-title":"The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells","volume":"21","author":"Harris","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ccell.2018.02.002","article-title":"ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia","volume":"33","author":"Maes","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jtho.2022.05.014","article-title":"Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC","volume":"17","author":"Nguyen","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.drudis.2025.104397_b0030","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-22-2433","article-title":"LSD1 Inhibition disrupts super-enhancer-driven oncogenic transcriptional programs in castration-resistant prostate cancer","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2025.104397_b0035","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41594-022-00856-x","article-title":"Endocrine resistance and breast cancer plasticity are controlled by CoREST","volume":"29","author":"Garcia-Martinez","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2025.104397_b0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2017.03.038","article-title":"Targeting KDM1A attenuates Wnt\/\u03b2-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma","volume":"398","author":"Huang","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2025.104397_b0045","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/jn\/nxac080","article-title":"Lysine-specific demethylase 1 in energy metabolism: a novel target for obesity","volume":"152","author":"Wang","year":"2022","journal-title":"J Nutr"},{"key":"10.1016\/j.drudis.2025.104397_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-021-00737-3","article-title":"Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases","volume":"28","author":"Kim","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.drudis.2025.104397_b0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0060","doi-asserted-by":"crossref","first-page":"13956","DOI":"10.1073\/pnas.0606381103","article-title":"Crystal structure of human histone lysine-specific demethylase 1 (LSD1)","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104397_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217093","article-title":"Targeting LSD1 in cancer: molecular elucidation and recent advances","volume":"598","author":"Cai","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2025.104397_b0070","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","article-title":"LSD1: more than demethylation of histone lysine residues","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2025.104397_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101684","article-title":"CREB3 facilitates donafenib resistance in hepatocellular carcinoma cells via the LSD1\/CoREST\/p65 axis by transcriptionally activating long noncoding RNA ZFAS1","volume":"44","author":"Hou","year":"2024","journal-title":"Transl Oncol"},{"key":"10.1016\/j.drudis.2025.104397_b0080","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00018-020-03489-9","article-title":"Biological roles of LSD1 beyond its demethylase activity","volume":"77","author":"Gu","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2025.104397_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbalip.2018.04.016","article-title":"Genetic and epigenetic control of adipose development","volume":"1864","author":"Gulyaeva","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.drudis.2025.104397_b0090","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.apsb.2024.01.005","article-title":"Strategies that regulate LSD1 for novel therapeutics","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2025.104397_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105958","article-title":"Therapeutic potential of targeting LSD1\/ KDM1A in cancers","volume":"175","author":"Zhang","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104397_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1120911","article-title":"LSD1 inhibitors for cancer treatment: focus on multi-target agents and compounds in clinical trials","volume":"14","author":"Noce","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104397_b0105","doi-asserted-by":"crossref","first-page":"14197","DOI":"10.1021\/acs.jmedchem.0c00919","article-title":"Tranylcypromine based lysine-specific demethylase 1 inhibitor: summary and perspective","volume":"63","author":"Dai","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104397_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113934","article-title":"Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance","volume":"157","author":"Agboyibor","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2025.104397_b0115","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1038\/s41467-023-40606-1","article-title":"Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition","volume":"14","author":"Zeng","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104397_b0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tips.2025.01.006","article-title":"Leveraging non-enzymatic functions of LSD1 for novel therapeutics","volume":"46","author":"Song","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2025.104397_b0125","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1182\/blood.2020005827","article-title":"Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171","volume":"136","author":"Subramaniam","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2025.104397_b0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2019.06.006","article-title":"Connections between metabolism and epigenetics in cancers","volume":"57","author":"Thakur","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.drudis.2025.104397_b0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0140","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104397_b0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2025.104397_b0150","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cmet.2020.04.022","article-title":"A metabolic roadmap for somatic stem cell fate","volume":"31","author":"Ly","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2025.104397_b0155","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104397_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12964-020-00586-x","article-title":"Regulators of glucose uptake in thyroid cancer cell lines","volume":"18","author":"Heydarzadeh","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.drudis.2025.104397_b0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0170","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100294","article-title":"Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth","volume":"37","author":"Cox","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2025.104397_b0175","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2025.104397_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ncb1724","article-title":"p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation","volume":"10","author":"Kawauchi","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2025.104397_b0190","doi-asserted-by":"crossref","first-page":"e2820","DOI":"10.1038\/cddis.2017.85","article-title":"PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2025.104397_b0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104397_b0200","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.bbamcr.2015.12.017","article-title":"Glutamine transporters in mammalian cells and their functions in physiology and cancer","volume":"1863","author":"Bhutia","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2025.104397_b0205","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cells9102308","article-title":"Cancer metabolism: phenotype, signaling and therapeutic targets","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104397_b0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/path.4429","article-title":"ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation","volume":"235","author":"Ren","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.drudis.2025.104397_b0215","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1878-0261.12999","article-title":"Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1","volume":"15","author":"Kandasamy","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.drudis.2025.104397_b0220","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212171","article-title":"Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells","volume":"42","author":"Wang","year":"2022","journal-title":"Biosci Rep"},{"key":"10.1016\/j.drudis.2025.104397_b0225","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2015.09.025","article-title":"Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation","volume":"22","author":"Bott","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2025.104397_b0230","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.1038\/ncomms11321","article-title":"The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy","volume":"7","author":"Lukey","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104397_b0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2018.04.002","article-title":"The GSK3 signaling axis regulates adaptive glutamine metabolism in lung squamous cell carcinoma","volume":"33","author":"Momcilovic","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0240","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104397_b0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","article-title":"Emerging targets in lipid metabolism for cancer therapy","volume":"45","author":"Terry","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2025.104397_b0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.drudis.2025.104397_b0255","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2025.104397_b0260","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ejmech.2018.09.001","article-title":"ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism","volume":"157","author":"Granchi","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104397_b0265","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","article-title":"De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy","volume":"100","author":"Mashima","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.drudis.2025.104397_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.916661","article-title":"The role of lipid metabolism in gastric cancer","volume":"12","author":"Cui","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2025.104397_b0275","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","article-title":"ACLY facilitates colon cancer cell metastasis by CTNNB1","volume":"38","author":"Wen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2025.104397_b0280","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1101\/gad.283283.116","article-title":"Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression","volume":"30","author":"Zhang","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.drudis.2025.104397_b0285","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate dependence of tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","article-title":"Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2025.104397_b0295","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.29714","article-title":"Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer","volume":"138","author":"Kosumi","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.drudis.2025.104397_b0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J Physiol"},{"key":"10.1016\/j.drudis.2025.104397_b0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2014.02.013","article-title":"LSD1 sustains pancreatic cancer growth via maintaining HIF1\u03b1-dependent glycolytic process","volume":"347","author":"Qin","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2025.104397_b0310","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/0008-5472.CAN-14-1560","article-title":"Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells","volume":"75","author":"Sakamoto","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2025.104397_b0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13046-022-02412-3","article-title":"NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer","volume":"41","author":"Jing","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2025.104397_b0320","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1038\/onc.2010.120","article-title":"LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription","volume":"29","author":"Amente","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2025.104397_b0325","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells","volume":"20","author":"Yan","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2025.104397_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.694071","article-title":"KRT6A promotes lung cancer cell growth and invasion through MYC-regulated pentose phosphate pathway","volume":"9","author":"Che","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2025.104397_b0335","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/bloodadvances.2020003521","article-title":"LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C\/EBP\u03b1","volume":"5","author":"Kohrogi","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.drudis.2025.104397_b0340","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3389\/fphar.2018.01411","article-title":"ORY-1001 suppresses cell growth and induces apoptosis in lung cancer through triggering HK2 mediated Warburg effect","volume":"9","author":"Lu","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104397_b0345","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-018-0947-4","article-title":"LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer","volume":"37","author":"Feng","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2025.104397_b0350","article-title":"Adipocytic glutamine synthetase upregulation via altered histone methylation promotes 5FU chemoresistance in peritoneal carcinomatosis of colorectal cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2025.104397_b0355","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccr.2013.02.024","article-title":"SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism","volume":"23","author":"Jeong","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0360","doi-asserted-by":"crossref","first-page":"e2631","DOI":"10.1038\/cddis.2017.48","article-title":"Inactivation of Lsd1 triggers senescence in trophoblast stem cells by induction of Sirt4","volume":"8","author":"Castex","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2025.104397_b0365","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","article-title":"Meta-hallmarks of aging and cancer","volume":"35","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2025.104397_b0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00109-011-0726-6","article-title":"mTOR links oncogenic signaling to tumor cell metabolism","volume":"89","author":"Yecies","year":"2011","journal-title":"J Mol Med"},{"key":"10.1016\/j.drudis.2025.104397_b0375","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cell.2013.04.023","article-title":"The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4","volume":"153","author":"Csibi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0380","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.2147\/OTT.S207238","article-title":"LSD1 regulates Notch and PI3K\/Akt\/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma","volume":"12","author":"Hou","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.drudis.2025.104397_b0385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2019.03.052","article-title":"ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4\/mTOR pathway","volume":"454","author":"Li","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2025.104397_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116696","article-title":"Knockdown of LSD1 meliorates Ox-LDL-stimulated NLRP3 activation and inflammation by promoting autophagy via SESN2-mesiated PI3K\/Akt\/mTOR signaling pathway","volume":"233","author":"Zhuo","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.drudis.2025.104397_b0395","doi-asserted-by":"crossref","first-page":"30034","DOI":"10.1074\/jbc.M110.151209","article-title":"Histone demethylase LSD1 regulates adipogenesis","volume":"285","author":"Musri","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2025.104397_b0400","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4161\/19336918.2014.972740","article-title":"SLUG: critical regulator of epithelial cell identity in breast development and cancer","volume":"8","author":"Phillips","year":"2014","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.drudis.2025.104397_b0405","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI128073","article-title":"Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes","volume":"130","author":"Liu","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104397_b0410","doi-asserted-by":"crossref","first-page":"29937","DOI":"10.1074\/jbc.M114.573659","article-title":"Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 (LSD1)","volume":"289","author":"Abdulla","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2025.104397_b0415","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201400","article-title":"ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma","volume":"6","author":"Ferrarese","year":"2023","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.drudis.2025.104397_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101561","article-title":"Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics","volume":"64","author":"Chianese","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.drudis.2025.104397_b0425","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8184","article-title":"Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment","volume":"46","author":"Li","year":"2021","journal-title":"Oncol Rep"},{"key":"10.1016\/j.drudis.2025.104397_b0430","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2025.104397_b0435","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2025.104397_b0440","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood.2019001076","article-title":"AMP-activated protein kinase links acetyl-CoA homeostasis to BRD4 recruitment in acute myeloid leukemia","volume":"134","author":"Jiang","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2025.104397_b0445","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","article-title":"Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation","volume":"20","author":"Lee","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2025.104397_b0450","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2025.104397_b0455","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161713","article-title":"Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression","volume":"133","author":"Gou","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104397_b0460","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41467-021-21784-2","article-title":"Epigenetic modulation reveals differentiation state specificity of oncogene addiction","volume":"12","author":"Khaliq","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104397_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113757","article-title":"SIRT1 regulated hexokinase-2 promoting glycolysis is involved in hydroquinone-enhanced malignant progression in human lymphoblastoid TK6 cells","volume":"241","author":"Chen","year":"2022","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.drudis.2025.104397_b0470","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3389\/fimmu.2020.02196","article-title":"Scaffolding LSD1 inhibitors impair NK cell metabolism and cytotoxic function through depletion of glutathione","volume":"11","author":"Bailey","year":"2020","journal-title":"Front Immunol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:37:30Z","timestamp":1762371450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1359644625001102"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104397","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic roles of lysine-specific demethylase 1 (LSD1) in cancer metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104397"}}